Interleukin-10: An Anti-Inflammatory Marker To Target Atherosclerotic Lesions via PEGylated Liposomes
Open Access
- 4 December 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 10 (1) , 175-186
Abstract
Atherosclerosis (AS) causes cardiovascular disease, which leads to fatal clinical end points like myocardial infarction or stroke, the most prevalent causes of death in developed countries. An early, noninvasive method of detection and diagnosis of atherosclerotic lesions is necessary to prevent and treat these clinical end points. Working toward this goal, we examined recombinant interleukin-10 (IL-10), stealth liposomes with nanocargo potency for NMRI relevant contrast agents, and IL-10 coupled to stealth liposomes in an ApoE-deficient mouse model using confocal laser-scanning microscopy (CLSM). Through ex vivo incubation and imaging with CLSM, we showed that fluorescently labeled IL-10 is internalized by AS plaques, and a low signal is detected in both the less injured aortic surfaces and the arteries of wild-type mice. In vivo experiments included intravenous injections of (i) fluorescent IL-10, (ii) IL-10 targeted carboxyfluorescin (CF−) labeled stealth liposomes, and (iii) untargeted CF-labeled stealth liposomes. Twenty-four hours after injection the arteries were dissected and imaged ex vivo. Compared to free IL-10, we observed a markedly stronger fluorescence intensity with IL-10 targeted liposomes at AS plaque regions. Moreover, untargeted CF-labeled liposomes showed only weak, unspecific binding. Neither free IL-10 nor IL-10 targeted liposomes showed significant immune reaction when injected into wild-type mice. Thus, the combined use of specific anti-inflammatory proteins, high payloads of contrast agents, and liposome particles should enable current imaging techniques to better recognize and visualize AS plaques for research and prospective therapeutic strategies.Keywords
This publication has 57 references indexed in Scilit:
- Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probesInternational Journal of Nanomedicine, 2012
- Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesionsBiologics: Targets and Therapy, 2011
- Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaquesInternational Journal of Nanomedicine, 2011
- Targeted Liposomal Drug Delivery to Monocytes and MacrophagesJournal of Drug Delivery, 2010
- Antacids and dietary supplements with an influence on the gastric pH increase the risk for food sensitizationClinical & Experimental Allergy, 2010
- Targeted Probes for Cardiovascular MRIFuture Medicinal Chemistry, 2010
- Nanotechnology in Medical ImagingArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Molecular Imaging in Atherosclerosis, Thrombosis, and Vascular InflammationArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Interleukin‐10: new perspectives on an old cytokineImmunological Reviews, 2008
- MR-optical imaging of cardiovascular molecular targetsBasic Research in Cardiology, 2008